Literature DB >> 17405941

Update in cystic fibrosis 2006.

Frank J Accurso1.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17405941      PMCID: PMC2720114          DOI: 10.1164/rccm.200701-160UP

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  34 in total

1.  Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis.

Authors:  Leslie A Kalish; David A Waltz; Mark Dovey; Gail Potter-Bynoe; Alexander J McAdam; John J Lipuma; Craig Gerard; Donald Goldmann
Journal:  Am J Respir Crit Care Med       Date:  2005-11-04       Impact factor: 21.405

2.  Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.

Authors:  Anna M van Heeckeren; Mark D Schluchter; Wei Xue; Pamela B Davis
Journal:  Am J Respir Crit Care Med       Date:  2005-11-04       Impact factor: 21.405

3.  Laboratory parameter profiles among patients with cystic fibrosis.

Authors:  Christopher H Goss; Nicole Mayer-Hamblett; Richard A Kronmal; Judy Williams; Bonnie W Ramsey
Journal:  J Cyst Fibros       Date:  2006-07-07       Impact factor: 5.482

Review 4.  The inflammatory role of platelets in cystic fibrosis.

Authors:  Brian P O'Sullivan; Alan D Michelson
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

5.  Clinical trial participants compared with nonparticipants in cystic fibrosis.

Authors:  Christopher H Goss; Gordon D Rubenfeld; Bonnie W Ramsey; Moira L Aitken
Journal:  Am J Respir Crit Care Med       Date:  2005-09-28       Impact factor: 21.405

6.  A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

Authors:  Mark R Elkins; Michael Robinson; Barbara R Rose; Colin Harbour; Carmel P Moriarty; Guy B Marks; Elena G Belousova; Wei Xuan; Peter T P Bye
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

7.  Mucus clearance and lung function in cystic fibrosis with hypertonic saline.

Authors:  Scott H Donaldson; William D Bennett; Kirby L Zeman; Michael R Knowles; Robert Tarran; Richard C Boucher
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

Review 8.  Cystic fibrosis since 1938.

Authors:  Pamela B Davis
Journal:  Am J Respir Crit Care Med       Date:  2005-08-26       Impact factor: 21.405

9.  Risk factors for death of patients with cystic fibrosis awaiting lung transplantation.

Authors:  Richard A Belkin; Noreen R Henig; Lianne G Singer; Cecilia Chaparro; Ronald C Rubenstein; Sharon X Xie; Justin Y Yee; Robert M Kotloff; David A Lipson; Greta R Bunin
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

10.  Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions.

Authors:  Sang Sun Yoon; Ray Coakley; Gee W Lau; Sergei V Lymar; Benjamin Gaston; Ahmet C Karabulut; Robert F Hennigan; Sung-Hei Hwang; Garry Buettner; Michael J Schurr; Joel E Mortensen; Jane L Burns; David Speert; Richard C Boucher; Daniel J Hassett
Journal:  J Clin Invest       Date:  2006-01-26       Impact factor: 14.808

View more
  11 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Life-space mobility is associated with frequency of hospitalization in adults with cystic fibrosis.

Authors:  Eric Raphael Gottlieb; Elisabeth Christine Smith; Linda Lucetta Wolfenden; Richard Mark Allman; Vin Tangpricha
Journal:  Clin Respir J       Date:  2010-10-01       Impact factor: 2.570

3.  Recombinant allergens combined with biological markers in the diagnosis of allergic bronchopulmonary aspergillosis in cystic fibrosis patients.

Authors:  Hélène Fricker-Hidalgo; Bérangère Coltey; Catherine Llerena; Jean-Charles Renversez; Renée Grillot; Isabelle Pin; Hervé Pelloux; Claudine Pinel
Journal:  Clin Vaccine Immunol       Date:  2010-07-14

4.  Vitamin D and bone health in adults with cystic fibrosis.

Authors:  Linda L Wolfenden; Suzanne E Judd; Reshma Shah; Rupan Sanyal; Thomas R Ziegler; Vin Tangpricha
Journal:  Clin Endocrinol (Oxf)       Date:  2008-02-11       Impact factor: 3.478

5.  Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis.

Authors:  Tanweer Zaidi; Milan Bajmoczi; Tauqeer Zaidi; David E Golan; Gerald B Pier
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

6.  Shwachman-Kulczycki score still useful to monitor cystic fibrosis severity.

Authors:  Fabíola Stollar; Fabíola Villac Adde; Maristela T Cunha; Claudio Leone; Joaquim C Rodrigues
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 7.  Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis.

Authors:  Molla Imaduddin Ahmed; Saptarshi Mukherjee
Journal:  Cochrane Database Syst Rev       Date:  2018-07-27

Review 8.  Inhaled mannitol for cystic fibrosis.

Authors:  Sarah J Nevitt; Judith Thornton; Clare S Murray; Tiffany Dwyer
Journal:  Cochrane Database Syst Rev       Date:  2018-02-09

9.  Higher mobility scores in patients with cystic fibrosis are associated with better lung function.

Authors:  Aneesha Thobani; Jessica A Alvarez; Shaina Blair; Kaila Jackson; Eric R Gottlieb; Seth Walker; Vin Tangpricha
Journal:  Pulm Med       Date:  2015-02-18

10.  Inhaled mannitol for cystic fibrosis.

Authors:  Sarah J Nevitt; Judith Thornton; Clare S Murray; Tiffany Dwyer
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.